Can ^<18>F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
Mester Janos
Department Of Nuclear Medicine University Medical Center
-
Derlin Thorsten
Department Of Nuclear Medicine University Medical Center
-
Apostolova Ivayla
Department Of Nuclear Medicine University Medical Center
-
Klutmann Susanne
Department Of Nuclear Medicine University Medical Center
-
Bannas Peter
Department Of Diagnostic And Interventional Radiology University Medical Center Hamburg-eppendorf
-
GROTH Michael
Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf
-
ADAM Gerhard
Department of Diagnostic and Interventional Radiology, University Medical Center Hamburg-Eppendorf
-
Adam Gerhard
Department Of Diagnostic And Interventional Radiology University Medical Center Hamburg-eppendorf
-
Groth Michael
Department Of Diagnostic And Interventional Radiology University Medical Center Hamburg-eppendorf
-
Apostolova Ivayla
Department Of Nuclear Medicine Charite-universitatsmedizin
関連論文
- SPECT/CT stabilizes the interpretation of somatostatin receptor scintigraphy findings : a retrospective analysis of inter-rater agreement
- Impact of additional SPECT in bone scanning in tumor patients with suspected metastatic bone disease
- Quantification of [^F]-FDG uptake in atherosclerotic plaque : impact of renal function
- Can ^F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?